Literature DB >> 18422969

Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.

Brian M Necela1, Weidong Su, E Aubrey Thompson.   

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed in macrophages and plays an important role in suppressing the inflammatory response. Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines. Moreover, pretreatment with the synthetic PPARgamma ligand, rosiglitazone did not prevent LPS-mediated downregulation of PPARgamma. Inhibition of PPARgamma expression was not blocked by cycloheximide, indicating that de novo protein synthesis is not required for LPS-mediated suppression of PPARgamma. Destabilization of PPARgamma messenger RNA (mRNA) was not observed in LPS-stimulated macrophages, suggesting that LPS regulates the synthesis of PPARgamma mRNA. LPS had no effect on PPARgamma expression in macrophages from TLR4 knockout mice, whereas LPS inhibited PPARgamma expression in cells that had been reconstituted to express functional TLR4. Targeting the TLR4 pathway with inhibitors of MEK1/2, p38, JNK and AP-1 had no effect on PPARgamma downregulation by LPS. However, inhibitors that target NEMO, IkappaB and NF-kappaB abolished LPS-mediated downregulation of PPARgamma in LPS-stimulated macrophages. Our data indicate that activation of TLR4 inhibits PPARgamma mRNA synthesis by an NF-kappaB-dependent mechanism. Low-density genomic profiling of macrophage-specific PPARgamma knockout cells indicated that PPARgamma suppresses inflammation under basal conditions, and that loss of PPARgamma expression is sufficient to induce a proinflammatory state. Our data reveal a regulatory feedback loop in which PPARgamma represses NF-kappaB-mediated inflammatory signalling in unstimulated macrophages; however, upon activation of TLR4, NF-kappaB drives down PPARgamma expression and thereby obviates any potential anti-inflammatory effects of PPARgamma in LPS-stimulated macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422969      PMCID: PMC2669138          DOI: 10.1111/j.1365-2567.2008.02849.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  75 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

Authors:  J Y Lee; K H Sohn; S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2001-03-02       Impact factor: 5.157

3.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

4.  Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.

Authors:  K J Waite; Z E Floyd; P Arbour-Reily; J M Stephens
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

Review 5.  Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways.

Authors:  D Hwang
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

6.  PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.

Authors:  A Chawla; Y Barak; L Nagy; D Liao; P Tontonoz; R M Evans
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

7.  Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

Authors:  A C Li; K K Brown; M J Silvestre; T M Willson; W Palinski; C K Glass
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 8.  Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

Authors:  K J Moore; M L Fitzgerald; M W Freeman
Journal:  Curr Opin Lipidol       Date:  2001-10       Impact factor: 4.776

9.  An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Authors:  J D Lewis; G R Lichtenstein; R B Stein; J J Deren; T A Judge; F Fogt; E E Furth; E J Demissie; L B Hurd; C G Su; S A Keilbaugh; M A Lazar; G D Wu
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

10.  Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.

Authors:  P Desreumaux; L Dubuquoy; S Nutten; M Peuchmaur; W Englaro; K Schoonjans; B Derijard; B Desvergne; W Wahli; P Chambon; M D Leibowitz; J F Colombel; J Auwerx
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  45 in total

1.  Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages.

Authors:  Sara L Coleman; Young-Ki Park; Ji-Young Lee
Journal:  Eur J Nutr       Date:  2010-11-03       Impact factor: 5.614

2.  Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitis.

Authors:  Shelly R Calcagno; Shuhua Li; Muhammad W Shahid; Michael B Wallace; Michael Leitges; Alan P Fields; Nicole R Murray
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

3.  Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activation.

Authors:  Hong Guo; Daozhong Jin; Xiaoli Chen
Journal:  Mol Endocrinol       Date:  2014-08-15

4.  Analgesic tolerance to morphine is regulated by PPARγ.

Authors:  Giordano de Guglielmo; Marsida Kallupi; Giulia Scuppa; Serena Stopponi; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.

Authors:  Gillian L Fell; Bennet S Cho; Duy T Dao; Lorenzo Anez-Bustillos; Meredith A Baker; Prathima Nandivada; Amy Pan; Alison A O'Loughlin; Paul D Mitchell; Vania Nose; Kathleen M Gura; Mark Puder
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-03-05       Impact factor: 4.006

6.  TLR4 and Insulin Resistance.

Authors:  Jane J Kim; Dorothy D Sears
Journal:  Gastroenterol Res Pract       Date:  2010-08-10       Impact factor: 2.260

Review 7.  Endocannabinoids in synaptic plasticity and neuroprotection.

Authors:  Jian-Yi Xu; Chu Chen
Journal:  Neuroscientist       Date:  2014-02-25       Impact factor: 7.519

8.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

9.  PPARγ ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2.

Authors:  Reyhaneh Darehgazani; Maryam Peymani; Motahare-Sadat Hashemi; Mir Davood Omrani; Abolfazl Movafagh; Kamran Ghaedi; Mohammad Hossein Nasr-Esfahani
Journal:  Cytotechnology       Date:  2015-07-30       Impact factor: 2.058

10.  Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.

Authors:  Tommaso Mello; Simone Polvani; Andrea Galli
Journal:  PPAR Res       Date:  2009-09-14       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.